HIF1A and B-cell chronic lymphocytic leukemia: In chronic lymphocytic leukemia (CLL), HIF-1α promotes bone marrow neovascularization, regulates the expression of chemokine receptors and cell adhesion molecules (such as CXCR 4, CXCL 12, etc.), thereby maintaining CLL cells survival within the bone marrow microenvironment [82].